Cryo-Save Group N.V.: Grant of share options

Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), the leading international stem cell storage brand and the largest family stem cell bank in Europe, announces that the Group granted options to subscribe for ordinary shares in the Company under the Cryo-Save Group 2009 Share Option Scheme on 2 April 2012.

The Group granted 20,000 options to Arnoud van Tulder, Chief Executive Officer, and 44,000 options to certain other employees of the Group all at an exercise price of €3.93 per share, being the price equal to the arithmetic average of the closing mid-market price over the five dealing days prior to the date of the grant. All of these options are exercisable at any time from 3 April 2015 until 3 April 2022.

The Group now has a total of 304,000 options over ordinary shares outstanding.

Enquiries:

Cryo-Save Group	+ 31 (0) 575 548 998
Arnoud van Tulder, Chief Executive Officer

SPJ Financiële Communicatie (The Netherlands)	+31 (0)20 647 8181
Kees Jongsma/Leon Melens

Daniel Stewart & Company plc (UK)	+ 44 (0) 20 7776 6550
Martin Lampshire

College Hill (UK)	+ 44 (0) 20 7457 2020
Rozi Morris/ Adrian Duffield

Free footage is available on www.videobankonline.com.

About Cryo-Save (www.cryo-save.com/group)

Cryo-Save, the leading international stem cell storage brand and the largest family stem cell bank in Europe, already stores more than 204,000 samples from cord blood and umbilical cord tissue for newborns and adipose tissue for adults. These stem cells can mean the difference between life and death in the case of future threats to the health of the donors. There are already several diseases that can be treated by the use of stem cells, and the number of treatments will only increase. The use of stem cells from adipose tissue is increasingly popular in plastic surgery. Driven by its international business strategy, Cryo-Save is now represented in over 40 countries on four continents, with ultra-modern processing and storage facilities in the United States, Belgium, Germany, Dubai, India, South Africa and France (validation in progress).

Cryo-Save Group N.V.: Grant of share options

Attachments